premenstrual syndrome hormonal biochemical profile, essential fatty acids treatment PMS randomized crossover trial, PMS aldosterone cholesterol follicular luteal phase differences, premenstrual syndrome glucose tolerance mineralocorticoids, essential fatty acids PMS double blind placebo controlled, hormonal parameters PMS versus symptom free controls, premenstrual syndrome magnesium calcium triglycerides, PMS biochemical markers menstrual cycle phases, aldosterone deficiency premenstrual syndrome luteal phase, apolipoprotein cholesterol PMS follicular phase abnormality
Keywords
Adult, Cholesterol/blood, Double-Blind Method, Electrolytes/blood, Fatty Acids, Essential/pharmacology/therapeutic Use, Female, Follicular Phase, Glucose Tolerance Test, Gonadal Steroid Hormones/blood, Humans, Hypolipidemic Agents/therapeutic Use, Linoleic Acids, Lipoprotein(a)/blood/drug Effects, Luteal Phase, Mineralocorticoids/blood, Oenothera Biennis, Plant Oils, Premenstrual Syndrome/blood/drug Therapy/physiopathology, Severity of Illness Index, Triglycerides/blood, gamma-Linolenic Acid, Electrolytes, Fatty Acids, Essential, Gonadal Steroid Hormones, Hypolipidemic Agents, Linoleic Acids, Lipoprotein(a), Mineralocorticoids, Plant Oils, Triglycerides, Evening Primrose Oil, gamma-Linolenic Acid, Cholesterol